








DIAGNOS announces issuance of CE certificate for CARA commercialization
DIAGNOS announces Representative IRIS in the USA.
DIAGNOS announces correction to a news release dated September 6, 2011.
DIAGNOS announces agreement to analyse Plan North of Quebec exploration data.
DIAGNOS announces nomination to the Board of Directors.
Gold sample assays up to 20.1 g/t, on targets identified by DIAGNOS CARDS technology.
DIAGNOS retains the services of Louis Morin for its investor relations activities.
Founded in 1998, DIAGNOS is a Canadian corporation (TSX: ADK) that develops and commercializes technologies that combine contextual imaging and traditional data mining to improve decision-making processes. DIAGNOS’ world-class products and services support clients in the healthcare, natural resources and entertainment industries.
The Condensed financial statements and the Management Discussion & Analysis (MD&A) reports (Q1-2012) for the Interim period ended June 30, 2011 are now availables.



DIAGNOS is currently developing CARA (Computer Assisted Retinal Analysis), a system that can be used to assist health care practitioners by dramatically enhancing retinal images, and automatically annotating abnormal findings.
CARDS (Computer Aided Resources Detection System) is a state-of-the-art computer system used by researchers at DIAGNOS to identify areas with a high probability of containing a significant mineral deposit.
DIAGNOS has developed DHS (Dynamic Hit Scoring), a technology that can predict if a song has the potential to be a hit.
| Last Trade: | 0.29 |
| Volume: | 400000 |
| Open: | 0.275 |
| High: | 0.30 |
| Low: | 0.25 |
| Change: | +0.01 |
|
|
|




































